RecruitingNot ApplicableNCT07611968

Prospective Evaluation of Physician Modified Endografts for Aortic Disease

Sponsor

Mayo Clinic

Enrollment

20 participants

Start Date

Jul 10, 2026

Study Type

INTERVENTIONAL

Conditions

Aortic Aneurysm

Summary

The purpose of this research is to assess safety and preliminary effectiveness of the Physician-Modified Terumo Treo Abdominal Stent-Graft System.

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Physician-Modified Terumo Treo Abdominal Stent-Graft System for people with aortic aneurysm. The study is currently recruiting participants at 1 location. People eligible for this study include aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPhysician-Modified Terumo Treo Abdominal Stent-Graft System

A physician modified Terumo Treo abdominal stent-graft system will be used during repair surgery for type II, III and IV thoracoabdominal aortic aneurysms.

Locations(1)

Mayo Clinic

Jacksonville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07611968

Related Trials

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

NCT0707838322 locations

Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms

NCT065018721 location